Drug Search Results
More Filters [+]

Streptokinase

Alternative Names: streptokinase
Latest Update: 2024-08-09
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: PLA Activator

Novel Mechanism: No

Modality: N/A

Route of Administration: Intravenous,Percutaneous

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Bangladesh | Brazil | Bulgaria | Canada | Chile | Colombia | Denmark | Dominican Republic | Ecuador | Egypt | Germany | Greece | India | Indonesia | Ireland | Israel | Italy | Jordan | Korea | Malaysia | Malta | Mexico | Morocco | New Zealand | Pakistan | Peru | Philippines | Poland | Portugal | Russia | Slovenia | South Africa | Spain | Sri Lanka | Sweden | Taiwan | Thailand | Ukraine | United Kingdom | Uruguay | Venezuela | Vietnam

Approved Indications: None

Known Adverse Events: None

Company: None
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Streptokinase

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Recent News Events